2006•Zhongguo linchuang yixueRequires access

The Efficacy and Sofery of Topiram in Patients with Epilepsy

Shandan Ouyang

Open publisher page 0 citations

Abstract

Objective:To observe the clinical efficacy and adverse reaction(AR)of topiramate(TPM)in treatment of epilepsy, and to explore the optimal mode of administration.Methods:One hundred and ninety-nine patients with epilepsy were divided into two groups according to different starting dose and the rate of increasing dosage,Group A (102 cases),the starting dose of TPM was 25 mg/d and the increasing dos-age per week was 25 mg until 200 mg/d was reached and then maintained for 12 wks;Group B(97 cases),the starting dose of TPM was 50mg/d and the increasing dosage per week was 50 mg until 200 mg// d was reached and then maintained for 12 weeks.Results:The total effective rate and controlrate in Group A were 77.7% and 42.1%;whereas those in Group B were 76.2 and 40.2,respectively.Significant difference was found between both groups(P>0.05).More ARs were observed in Group B as compared with Group A (P<0.05).Conclusion:A small starting dose fol- lowed by slowly increasing dosage is recommended to patients with lower seizure frequency.

About this research paper

What this paper is about

Objective:To observe the clinical efficacy and adverse reaction(AR)of topiramate(TPM)in treatment of epilepsy, and to explore the optimal mode of administration.Methods:One hundred and ninety-nine patients with epilepsy were divided into two groups according to different starting dose and the rate of increasing dosage,Group A (102 cases),the starting dose of TPM was 25 mg/d and the increasing dos-age per week was 25 mg until 200 mg/d was reached and then maintained for 12 wks;Group B(97 cases),the starting dose of TPM was 50mg/d and the increasing dosage per week was 50 mg until 200 mg// d was reached and then maintained for 12 weeks.Results:The total effective rate and controlrate in Group A were 77.7% and 42.1%;whereas those in Group B were 76.2 and 40.2,respectively.Significant difference was found between both groups(P>0.05).More ARs were observed in Group B as compared with Group A (P<0.05).Conclusion:A small starting dose fol- lowed by slowly increasing dosage is recommended to patients with lower seizure frequency.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the clinical efficacy and adverse reaction(AR)of topiramate(TPM)in treatment of epilepsy, and to explore the optimal mode of administration.Methods:One hundred and ninety-nine patients with epilepsy were divided into two groups according to different starting dose and the rate of increasing dosage,Group A (102 cases),the starting dose of TPM was 25 mg/d and the increasing dos-age per week was 25 mg until 200 mg/d was reached and then maintained for 12 wks;Group B(97 cases),the starting dose of TPM was 50mg/d and the increasing dosage per week was 50 mg until 200 mg// d was reached and then maintained for 12 weeks.Results:The total effective rate and controlrate in Group A were 77.7% and 42.1%;whereas those in Group B were 76.2 and 40.2,respectively.Significant difference was found between both groups(P>0.05).More ARs were observed in Group B as compared with Group A (P<0.05).Conclusion:A small starting dose fol- lowed by slowly increasing dosage is recommended to patients with lower seizure frequency.

Key concepts: Medicine, Topiramate, Epilepsy, Anesthesia, Adverse effect, Group B, Clinical efficacy, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
The Efficacy and Sofery of Topiram in Patients with Epilepsy — Research Paper | ScholarLens